Lee, H-H <br/><br/>
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.  [electronic resource] 

 -  The British journal of dermatology  Mar 2007 
 - 486-91 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0007-0963 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2133.2007.07682.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--adverse effects<br/>Dermatitis, Atopic--chemically induced<br/>Drug Eruptions--etiology<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Immunologic Factors--adverse effects<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Opportunistic Infections--chemically induced<br/>Prospective Studies<br/>Psoriasis--chemically induced<br/>Receptors, Tumor Necrosis Factor<br/>Rheumatic Diseases--drug therapy<br/>Skin Diseases, Infectious--chemically induced<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors